Pharmacists as Interventionists continued...
References: 1. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990 Mar;47(3):533-43. PMID: 2316538. 2. Manasse HR Jr. Medication use in an imperfect world: drug misadventuring as an issue of public policy, Part 1. Am J Hosp Pharm. 1989 May;46(5):929-44. PMID: 2729301.
3. Manasse HR Jr. Medication use in an imperfect world: drug misadventuring as an issue of public policy, Part 2. Am J Hosp Pharm. 1989 Jun;46(6):1141-52. PMID: 2750765.
4.
https://www.actuary.org/sites/default/fi les/fi les/publications/PrescriptionDrugs.030718.pdf. Accessed 05-31-24. 5. Watanabe JH, McInnis T, Hirsch JD. Cost of Prescription Drug-Related Morbidity and Mortality. Ann Pharmacother. 2018 Sep;52(9):829-837. doi: 10.1177/1060028018765159. Epub 2018 Mar 26. PMID: 29577766.
6. McDonough RP, Doucette WR. Building working relationships with providers. J Am Pharm Assoc (2003). 2003 Sep-Oct;43(5 Suppl 1):S44-5. doi: 10.1331/154434503322612447. PMID: 14626530.
7. Strand LM, Cipolle RJ, Morley PC. Documenting the clinical pharmacist's activities: back to basics. Drug Intell Clin Pharm. 1988 Jan;22(1):63-7. doi: 10.1177/106002808802200116. PMID: 3349924.
8. Pharmaceutical Care Practice: T e Patient-Centered Approach to Medication Management, T ird Edition Cipolle R, Strand L, Morley P. New York, NY: McGraw-Hill; 2012.
16 Missouri PHARMACIST | Volume 98, Issue II | Summer 2024
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
